Drug intelligence / Profile preview

tea tree oil + rosemary oil + clove oil + pepper oil + limonene

Development stage
Unknown
Modality
Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
Administration
Topical
01

Overview

This is a **combination topical formulation consisting of tea tree oil, rosemary oil, clove oil, pepper oil, and limonene**. Each component is an essential oil widely recognized for its natural bioactive constituents. The combination is being investigated as a *topical therapy*, particularly as a skin-permeation-enhancing blend for localized relief such as in plantar fasciitis, based on available clinical trial data[1]. - **Tea tree oil** (*Melaleuca alternifolia* oil): Contains active terpenes such as α-pinene and limonene and demonstrates antimicrobial, anti-inflammatory, and local anesthetic activities, largely through disruption of microbial cell membranes and modulation of inflammatory mediators[3][4]. - **Rosemary oil** (*Rosmarinus officinalis* oil): Exhibits antinociceptive (pain-relieving), antioxidant, and anti-inflammatory properties through its phenolic compounds and terpenes. - **Clove oil** (*Syzygium aromaticum* oil): Rich in eugenol, a compound with well-documented analgesic (pain-relieving), antimicrobial, and anti-inflammatory activities mainly via membrane disruption and enzymatic inhibition pathways. - **Pepper oil** (commonly *Piper nigrum* oil): Demonstrates local stimulation, warming, and possibly analgesic and anti-microbial effects, attributed to piperine and related alkaloids. - **Limonene** (a monoterpene): Potent skin penetration enhancer; fluidizes stratum corneum lipids, increasing transdermal drug delivery[2]. Limonene also has mild anti-inflammatory and local anesthetic actions. The mechanism of the combination is *multimodal*: facilitating enhanced transdermal penetration (through stratum corneum lipid disruption primarily via limonene and other terpenes), provision of local anti-inflammatory and analgesic actions, and broad-spectrum antimicrobial activity[2][3][4]. The product is not an approved pharmaceutical drug and is referred to in clinical study contexts primarily as a topical experimental blend for symptom relief.

02

Targets

TRPV1 (Transient receptor potential cation channel subfamily V member 1)COXStratum corneum lipid matrix

Beyond the preview

Go deeper on tea tree oil + rosemary oil + clove oil + pepper oil + limonene.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on tea tree oil + rosemary oil + clove oil + pepper oil + limonene.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call